Patent No. EP2346495 (titled "Pharmaceutical Formulation 514") was filed by Astrazeneca UK on Oct 5, 2009. The application was issued on May 24, 2023.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Apr 20, 2017 | LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Apr 28, 2023
Apr 28, 2023
Apr 21, 2023
Apr 17, 2023
Apr 17, 2023
Apr 17, 2023
Apr 17, 2023
Apr 17, 2023
Jan 16, 2023
Jan 16, 2023
Jan 16, 2023
Jan 9, 2023
Dec 21, 2022
Dec 8, 2022
Dec 8, 2022
Dec 8, 2022
Oct 25, 2022
Oct 25, 2022
Oct 13, 2022
Oct 12, 2022
Oct 12, 2022
Oct 12, 2022
Oct 7, 2022
Sep 28, 2022
Sep 23, 2022
Sep 22, 2022
Sep 22, 2022
Sep 22, 2022
Sep 19, 2022
Sep 19, 2022
Sep 19, 2022
Aug 18, 2022
Aug 12, 2022
Aug 12, 2022
Aug 12, 2022
Jul 7, 2022
Jul 6, 2022
Jul 4, 2022
Apr 26, 2022
Apr 21, 2022
Apr 21, 2022
Apr 21, 2022
Dec 15, 2021
Dec 3, 2021
Dec 3, 2021
Dec 3, 2021
Nov 30, 2021
Oct 21, 2021
Oct 21, 2021
Oct 8, 2021
Oct 8, 2021
Oct 8, 2021
Oct 8, 2021
Dec 18, 2020
Dec 18, 2020
Dec 9, 2020
Mar 25, 2020
Oct 22, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Oct 7, 2019
Jun 4, 2019
May 27, 2019
May 27, 2019
May 27, 2019
Apr 8, 2019
Mar 28, 2019
Mar 28, 2019
Mar 28, 2019
Mar 25, 2019
Mar 25, 2019
Mar 15, 2019
Mar 15, 2019
Mar 15, 2019
Mar 15, 2019
Jan 22, 2019
Jan 21, 2019
Jan 21, 2019
Jan 18, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Jan 17, 2019
Oct 16, 2018
Oct 4, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Sep 28, 2018
Aug 21, 2018
Aug 20, 2018
Aug 20, 2018
Aug 20, 2018
Aug 20, 2018
Aug 20, 2018
Aug 16, 2018
Aug 16, 2018
Aug 16, 2018
Aug 16, 2018
Aug 14, 2018
Aug 14, 2018
Aug 14, 2018
Aug 13, 2018
Aug 13, 2018
Aug 13, 2018
May 28, 2018
Apr 19, 2018
Apr 19, 2018
Apr 19, 2018
Apr 19, 2018
Mar 19, 2018
Mar 16, 2018
Mar 15, 2018
Mar 13, 2018
Mar 13, 2018
Mar 13, 2018
Mar 13, 2018
Mar 13, 2018
Mar 13, 2018
Mar 13, 2018
Jan 5, 2018
Oct 12, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Oct 6, 2017
Aug 8, 2017
Aug 2, 2017
Jul 10, 2017
Jun 9, 2017
Jun 9, 2017
Jun 9, 2017
May 30, 2017
May 30, 2017
May 3, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Apr 20, 2017
Jul 20, 2016
Jun 23, 2016
Jun 15, 2016
May 23, 2016
May 23, 2016
May 23, 2016
May 23, 2016
May 20, 2016
May 20, 2016
May 20, 2016
May 13, 2016
May 13, 2016
May 13, 2016
May 13, 2016
May 13, 2016
May 4, 2016
Mar 24, 2016
Mar 24, 2016
Mar 24, 2016
Mar 24, 2016
Mar 24, 2016
Mar 24, 2016
Mar 24, 2016
Feb 18, 2016
Feb 18, 2016
Feb 18, 2016
Feb 18, 2016
Feb 18, 2016
Oct 5, 2015
Oct 5, 2015
Oct 5, 2015
Oct 5, 2015
Oct 5, 2015
Oct 5, 2015
Oct 5, 2015
Sep 15, 2015
Sep 9, 2015
Sep 9, 2015
Sep 9, 2015
Sep 9, 2015
Jul 6, 2015
Jul 6, 2015
Jun 17, 2015
Jun 29, 2011
Jun 8, 2011
May 27, 2011
Apr 28, 2011
Apr 19, 2011
Apr 19, 2011
Apr 19, 2011
Apr 19, 2011
Apr 19, 2011
Apr 1, 2011
Feb 18, 2011
May 6, 2010
Apr 15, 2010
Apr 15, 2010
Dec 21, 2009
Dec 21, 2009
Dec 21, 2009
Nov 17, 2009
Oct 5, 2009
Oct 5, 2009
Oct 5, 2009
Oct 5, 2009